Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study

BACKGROUND: Incarcerated populations experience an elevated prevalence of opioid use disorder (OUD). Federal correctional institutions in Canada have increasingly treated OUD among correctional populations via opioid agonist treatment (OAT) – an evidence based pharmacotherapy that works to reduce dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Cayley, Nafeh, Frishta, Pang, Michelle, MacDonald, Shanna Farrell, Derkzen, Dena, Rehm, Jürgen, Fischer, Benedikt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897889/
https://www.ncbi.nlm.nih.gov/pubmed/35246083
http://dx.doi.org/10.1186/s12889-022-12685-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897889/
https://www.ncbi.nlm.nih.gov/pubmed/35246083
http://dx.doi.org/10.1186/s12889-022-12685-0

Ejemplares similares